Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Childs

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
Blood|November 1, 1994
Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical courseM C Shuhart, D Myerson, B H Childs, et al.
Blood|August 15, 1995
Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host diseaseS Mackinnon, E B Papadopoulos, M H Carabasi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 1997
Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantationA P Gillio, F Boulad, T N Small, et al.
Blood Advances|February 9, 2021
Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphomaPanayiotis Panayiotidis, George A Follows, Luigina Mollica, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE StudyHoward S Hochster, Lowell L Hart, Ramesh K Ramanathan, et al.
Cancer Research Communications|February 10, 2025
Safety and Efficacy of Copanlisib in Combination with Nivolumab: A Phase Ib Study in Patients with Advanced Solid TumorsBenedito A Carneiro, Robert M Jotte, Nashat Y Gabrail, et al.
Cancer Chemotherapy and Pharmacology|March 24, 2022
A phase I pharmacokinetic study of copanlisib in Chinese patients with relapsed indolent non-Hodgkin lymphomaWeiping Liu, Lingyan Ping, Yan Xie, et al.
Bone Marrow Transplantation|July 1, 1997
Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutisG Michel, F Boulad, T N Small, et al.
Gynecologic Oncology|January 31, 2014
A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tubeThomas J Herzog, Bradley J Monk, Peter G Rose, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast CancerJoseph A Sparano, Lori J Goldstein, Barrett H Childs, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
Blood|November 1, 1994
Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical courseM C Shuhart, D Myerson, B H Childs, et al.
Blood|August 15, 1995
Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host diseaseS Mackinnon, E B Papadopoulos, M H Carabasi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 1, 1997
Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantationA P Gillio, F Boulad, T N Small, et al.
Blood Advances|February 9, 2021
Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphomaPanayiotis Panayiotidis, George A Follows, Luigina Mollica, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE StudyHoward S Hochster, Lowell L Hart, Ramesh K Ramanathan, et al.
Cancer Research Communications|February 10, 2025
Safety and Efficacy of Copanlisib in Combination with Nivolumab: A Phase Ib Study in Patients with Advanced Solid TumorsBenedito A Carneiro, Robert M Jotte, Nashat Y Gabrail, et al.
Cancer Chemotherapy and Pharmacology|March 24, 2022
A phase I pharmacokinetic study of copanlisib in Chinese patients with relapsed indolent non-Hodgkin lymphomaWeiping Liu, Lingyan Ping, Yan Xie, et al.
Bone Marrow Transplantation|July 1, 1997
Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutisG Michel, F Boulad, T N Small, et al.
Gynecologic Oncology|January 31, 2014
A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tubeThomas J Herzog, Bradley J Monk, Peter G Rose, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast CancerJoseph A Sparano, Lori J Goldstein, Barrett H Childs, et al.
Pageof 9